The IMMUNOSYMPTOM Study
Currently recruiting participants to study immunotherapy, the gut microbiome, and adverse symptoms.
You may be eligible if you are:
- Ages 18-90
- Currently receiving immunotherapy treatment
- Willing to participate in a one-time, two-hour study session
- Able to communicate in English
The AISLEEP Study
Currently recruiting participants to study sleep disturbances and pain in breast cancer survivors on aromatase inhibitors.
You may be eligible if you are:
- Currently receiving the standard dose of aromatase inhibitor therapy (e.g. anastrozole, letrozole, exemestane, etc.)
- Ages 30-79
- Willing to participate in a one-time, one-hour study session
The AIMIC Study
Currently recruiting participants to study the role of gut microbiome in aromatase inhibitor-associated musculoskeletal symptoms and bone health in breast cancer survivors.
You may be eligible if you are:
- Currently receiving the standard dose of aromatase inhibitor therapy (e.g. anastrozole, letrozole, exemestane, etc.)
- Ages 30-79
- Willing to participate in a one-time, two-hour study session
The PATH Study
Currently recruiting participants for a study evaluating the benefits of movement and physical activity intervention among people with chronic low back pain.
You may be eligible if you are:
- Age 18 or older
- Have had low back pain for at least 3 of the last 6 months
- Have not practiced movement-based exercise in the past 3 months and are willing to attend 12 weeks of movement exercises
- Able to speak and read English
The Pain App Study
Participants Wanted for a Research Study to Examine the Efficacy of Smartphone Apps on Chronic Low Back Pain or Chronic Migraine.
You may be eligible if you:
- Have chronic low back pain or chronic migraine
- Ages 18 or older
- Are Fluent in English
- Don't have chronic conditions that affect inflammation (e.g., diabetes)